Somatostatin and Dopamine Receptor (Co-)Expression in Neuroendocrine Tumors with Ectopic ACTH Production: Potential Targets for Medical Treatment

Autor: RA Feelders, C de Bruin, AM Pereira, JA Romijn, AM Waaijers, RR de Krijger, DJ Kwekkeboom, SWJ Lamberts, WW de Herder, LJ Hofland

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::acfb510199d7305bfe800b26d82ee0d8
https://doi.org/10.1210/endo-meetings.2010.part1.p13.p1-649

Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

Autor: Kluiver TA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lu Y; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Xiamen, China., Schubert SA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kraaier LJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Ringnalda F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., DeMartino J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Megchelenbrink WL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Vico L. De Crecchio 7, Naples, Italy., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Faria FW; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Münter D; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Duiker E; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van den Heuvel MC; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., de Meijer VE; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Kleine RH; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands., Zsiros J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland., Peng WC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands. w.c.peng@prinsesmaximacentrum.nl.

Publikováno v: Nature communications [Nat Commun] 2024 Nov 20; Vol. 15 (1), pp. 8576. Date of Electronic Publication: 2024 Nov 20.

Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study.

Autor: Westerveld ASR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Endocrinology, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Imaging & Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Loonen J; Department of Hematology, Radboudumc Center of Expertise for Cancer Survivorship, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Netherlands Department of Pediatric Oncology/Hematology, Erasmus Medical Center, Rotterdam, the Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands., Koopman MMW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Janssens GO; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics Informatics and Epidemiology, University Medical Center of the JGU, Mainz, Germany., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 02, pp. JCO2301430. Date of Electronic Publication: 2024 Oct 02.

Direct correlation of MR-DWI and histopathology of Wilms' tumours through a patient-specific 3D-printed cutting guide.

Autor: van der Beek JN; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.n.vanderbeek-6@umcutrecht.nl.; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands. j.n.vanderbeek-6@umcutrecht.nl., Fitski M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Nikkels PGJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Maat A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Buser MAD; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hendrikse J; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Child Health, Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Littooij AS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Publikováno v: European radiology [Eur Radiol] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study.

Autor: van der Beek JN; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. j.n.vanderbeek-6@umcutrecht.nl.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.n.vanderbeek-6@umcutrecht.nl., Schenk JP; Clinic of Diagnostic and Interventional Radiology, Division of Pediatric Radiology, Heidelberg University Hospital, Heidelberg, Germany., Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Watson TA; Department of Paediatric Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Coma A; Department of Pediatric Radiology, Hospital Vall d'Hebron, Barcelona, Spain., Graf N; Department of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany., Chowdhury T; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Ramírez-Villar GL; Department of Paediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Spreafico F; Pediatric Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Welter N; Department of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany., Dzhuma K; Developmental Biology and Cancer Department, University College London Great Ormond Street Institute of Child Health, London, UK.; Department of Paediatric Urology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Child Health, Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands., Littooij AS; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Publikováno v: Pediatric radiology [Pediatr Radiol] 2024 May; Vol. 54 (6), pp. 965-976. Date of Electronic Publication: 2024 Apr 13.